TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. AAPL
6. DELL
7. NIO
8. ENOV
9. AON
10. A

Go back to TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) Delayed: 0.67 -0.06 (8.22%)
Previous Close $0.73    52 Week High $26.80 
Open $0.72    52 Week Low $23.00 
Day High $0.77    P/E N/A 
Day Low $0.66    EPS $0.00 
Volume 820,279